25 results
8-K
EX-99.2
PYXS
Pyxis Oncology Inc
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
and waste product removal; can also enable drug resistance that allows tumor to survive Why target the stroma? EDB+FN is a protein upregulated in tumor
424B3
gh7b0trk3q
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
upsj 0eyp6
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
0wt14d8
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
bhb54xpp78z2 y3
24 May 23
Business combination disclosure
7:05am
425
lid3z15scx7hof
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
ahb3lrr5dft ltcx6
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
10-K
bl0usjeh
29 Mar 22
Annual report
7:36am
10-Q
nwxmzh 6b3
15 Nov 21
Quarterly report
7:54am
424B4
qc65p30
8 Oct 21
Prospectus supplement with pricing info
5:00pm